ArticleOncology letters2020

Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway.

Yu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.